# Shanghai Taichu Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-taichu-biotechnology

- Industry: Outsourcing
- Headquarters: Shanghai, China
- Total disclosed funding: $102M
- Latest round: Series A (May 8, 2023)
- Investors on record: 13

## About

Established in 2020 and based in Shanghai, China, Skynor Medical operates as a CRO and CDMO customized services provider that provides CRO and CDMO technical services. Taijin Biology, Taili Biology, Taizhen Biology, and Taiji Biology are the subsidiaries of the company. In May 2023, it raised approximately CNY 400 million in series A funding led by IDG Capital.

The company provides CRO and CDMO technical services. CRO services include evaluation of non clinical drug efficacy in biopharmaceuticals and discovery of antibody drugs. CDMO services include R&D and production of antibody drug processes, high-end formulation delivery systems, and small nucleic acid processes.

## Funding rounds

- Series A, May 8, 2023, $58M — IDG Capital, Apricot Capital, Yijing Investment, Hangzhou Lula Asset Management, Juntong Capital, Shanghai Sci-Tech Innovation Center Capital, Zhongxin Capital, Hangzhou Aopeng Investment Management, Shanghai Healthcare Capital, Shanghai Boquan Equity Investment Management, Shijie Investment, Neux Capital
- Angel, Jul 18, 2022, $44M — TF Capital

## Investors

- TF Capital — Angel
- IDG Capital (https://capitalatlas.ai/funds/idg-capital) — Series A
- Apricot Capital (https://capitalatlas.ai/funds/apricot-capital) — Series A
- Yijing Investment (https://capitalatlas.ai/funds/yijing-investment) — Series A
- Hangzhou Lula Asset Management (https://capitalatlas.ai/funds/hangzhou-lula-asset-management) — Series A
- Juntong Capital (https://capitalatlas.ai/funds/juntong-capital) — Series A
- Shanghai Sci-Tech Innovation Center Capital (https://capitalatlas.ai/funds/shanghai-sci-tech-innovation-center-capital) — Series A
- Zhongxin Capital — Series A
- Hangzhou Aopeng Investment Management (https://capitalatlas.ai/funds/hangzhou-aopeng-investment-management) — Series A
- Shanghai Healthcare Capital (https://capitalatlas.ai/funds/shanghai-healthcare-capital) — Series A
- Shanghai Boquan Equity Investment Management — Series A
- Shijie Investment (https://capitalatlas.ai/funds/shijie-investment) — Series A
- Neux Capital — Series A